Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

3 Solid Pharma Stocks for a Healthy Year-End Portfolio

The pharma industry is transforming due to the rapid adoption of AI and global healthcare spending, fostering innovation and patient care advancements. Therefore, fundamentally sound pharma stocks Eli Lilly (LLY), Wave Life Sciences (WVE) and Johnson & Johnson (JNJ) might be worth adding to boost your portfolio. Continue reading.

StockNews.com

3 Pharma Powerhouses to Boost Your Year-End Investments

Backed by an ever-growing need for chronic disease treatments, rapid investments in research and development, and widespread integration of technology, the pharmaceutical sector is anticipated to flourish. Thus, as we approach the end of 2023, three solid pharma stocks, GoodRx Holdings (GDRX), CytomX Therapeutics (CTMX), and Neurocrine Biosciences (NBIX), could…

StockNews.com

Up First briefing: Trump won't testify; FDA approves landmark gene-editing treatment

Donald Trump plans to skip testifying for a second time in the New York civil fraud trial. The FDA has approved the first-ever gene-editing treatment for a human disease.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

The Rwanda plan is failing – so watch as our cowardly government blames the civil service

Ministers are spending £290m of taxpayers’ money on a scheme that is yet to deliver. It’s our job as public servants to point out flaws in their plans, says Dave Penman, general secretary of the FDA union

The Guardian - UK

How to protect against emerging STIs

From gonorrhea and syphilis to newer ailments, these are the STDs that you need to be on the watch for

Salon

Google could make the Pixel 8 Pro's thermometer a practical health feature

Code found in the Fitbit app suggests that it might soon be able to work with the Pixel 8 Pro's built-in thermometer.

Android Central

US approves two gene therapies for sickle cell disease

The U.S. Food and Drug Administration on Friday approved a pair of gene therapies for sickle cell disease, including the first treatment based on the breakthrough CRISPR gene editing technology.

The Hindu

Read news from The Economist, FT, and more,
with one subscription

1st gene therapies for sickle cell cleared by FDA, including CRISPR treatment

The FDA approved two new therapies for sickle-cell disease, including the world's first-ever approved CRISPR therapy.

LiveScience

Widely used epilepsy drugs tied to rare, deadly side effect, FDA warns

The announcement comes after the FDA became aware of more than 40 cases of "DRESS syndrome" linked to the seizure medications levetiracetam and clobazam.

LiveScience

FDA approves first gene-editing treatment for human illness

The Food and Drug Administration approved two genetic treatments for sickle cell disease, including one that uses gene-editing. The approvals offer hope for patients and signal a new medical era.

WEKU

“No Such Thing As Organic Honey”: 50 People Share Food Industry Secrets

Big money brings tough competition, and businesses can try all sorts of tactics to get an edge. The post “No Such Thing As Organic Honey”: 50 People Share Food Industry Secrets first appeared on Bored Panda.

Bored Panda

Lawmakers seek action against Elf Bar and other fruity e-cigarettes imported from China

House lawmakers are demanding information on federal efforts to stop the influx of kid-appealing electronic cigarettes from China

The Independent UK

3 Pharma Stocks Flashing 'Buy' Signals in December

The pharmaceutical industry is well-positioned for robust growth, driven by growing healthcare expenditure globally and the rapid adoption of digital technologies. Given the industry’s tailwinds, fundamentally strong pharma stocks, Collegium Pharmaceutical (COLL), Eton Pharmaceuticals (ETON), and GSK plc (GSK) could be ideal buys this month. Continue Reading….

StockNews.com

Two babies infected with rare bacteria sometimes found in powdered infant formula

A Kentucky child is dead and a Missouri infant has brain damage from the same kind of bacteria that sparked powdered formula recalls and shortages last year

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Rising Pharma Stocks to Consider Buying Now

The pharmaceutical sector is transforming due to the swift uptake of digital solutions and worldwide spending growth. Hence, fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Astellas Pharma (ALPMY), and Eli Lilly (LLY) might be solid buys now. Read more….

Reason

Will Abortion Issues Return to the Supreme Court?

The Court has been asked to intervene in cases involving abortion pills and criminal prosecution of abortion doctors.

LiveScience

Vaccine for superbugs? New shot shows promise in early tests

A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.

The Independent UK

White House delays menthol cigarette ban, alarming anti-smoking advocates

The White House is pushing back a plan to ban menthol cigarettes, an unexpected delay that quickly sparked criticism from anti-smoking groups

Get all your
news in one place.

100's of premium titles.
One news app.

Roll Call

FDA delays menthol ban following lobbying war - Roll Call

In a victory for the tobacco industry, the Biden administration is delaying a proposed ban on menthol cigarettes and flavored cigars.

The Independent UK

FDA is inspecting plant in Ecuador that made lead-tainted fruit pouches

U.S. health officials have launched an inspection of a plant in Ecuador that made the cinnamon applesauce pouches linked to dozens of cases of acute lead poisoning in U.S. children

StockNews.com

Analyzing December Profit Potential for the Top 4 Pharma Stocks

The global pharmaceutical market is witnessing robust growth, fueled by an escalating demand for healthcare services amid a burgeoning and aging population. Hence, fundamentally solid pharma stocks Novartis (NVS), Bristol-Myers Squibb (BMY), AbbVie (ABBV), and Taro Pharmaceutical (TARO) might be solid buys for gains this month. Read more.

Inverse

Which Weight Loss Drug Is Best And Safest? Here’s What Sets Them Apart

Earlier this month, the FDA approved Eli Lilly's Zepbound, a drug similar to its diabetes drug Mounjaro but specifically advertised for weight loss.

StockNews.com

This Small Cap Company is Revolutionizing Vascular Health

It’s no secret that the rate cycle, combined with an AI frenzy, greatly helped mega cap stocks this past year, and greatly harmed small cap stocks in need of capital. But, there may have been some throwing out the baby with the bath water activity in small caps that are…

USAFacts

What is the state of RSV in the United States?

RSV rates — which tend to climb in the fall and winter months — are highest for children under the age of five.

International Business Times

Chasing Weight Loss Dream, Many In US Seek Ozempic Alternatives

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.

1 … 116 117 118 119

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.